Fund moves
2.15MShares reported
6 tracked managers disclosed the same change for Q2 2025. From a 13F filed Aug 14, 2025 covering holdings at Jun 30, 2025 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Aug 6, 2025 · Filed Aug 6, 2025
The CEO of NeoGenomics Laboratories paid $100K out of pocket for NeoGenomics Laboratories shares. 1 other person at NeoGenomics Laboratories bought some too, in the same month. Shares held went up 89% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$99,954
Shares × reported transaction price
$25K–$100K
+88.8%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 3 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 1 earlier confirmed purchase
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
8 days after results of Jul 29, 2025, 83 days before results of Oct 28, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +7.6% | +2.0% | +5.6% |
| 30 days | +37.7% | +2.6% | +35.0% |
| 90 days | +81.1% | +7.2% | +73.9% |
| 180 days | +117.0% | +9.1% | +108.0% |
| 365 days | +187.7% | +22.3% | +165.4% |
Past results only. Not a forecast.
Fund moves
6 tracked managers disclosed the same change for Q2 2025. From a 13F filed Aug 14, 2025 covering holdings at Jun 30, 2025 — a quarter-end snapshot, not a live trade.
Fund moves
2 tracked managers disclosed the same change for Q2 2025. From a 13F filed Aug 14, 2025 covering holdings at Jun 30, 2025 — a quarter-end snapshot, not a live trade.
Insider buying
Traded Aug 6, 2025 · filed the same day
The CFO of NeoGenomics Laboratories paid $112K out of pocket for NeoGenomics Laboratories shares. 1 other person at NeoGenomics Laboratories bought some too, in the same month. Shares held went up 12% with this purchase.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.